Q4 2021 13F Holders as of 12/31/2021
-
Type / Class
-
Equity / Common Stock and American Depositary Receipts
-
Shares outstanding
-
1.23B
-
Number of holders
-
602
-
Total 13F shares, excl. options
-
244M
-
Shares change
-
+6.84M
-
Total reported value, excl. options
-
$12.2B
-
Value change
-
+$344M
-
Put/Call ratio
-
0.19
-
Number of buys
-
264
-
Number of sells
-
-232
-
Price
-
$50.10
Significant Holders of Sanofi - Common Stock and American Depositary Receipts (SNY) as of Q4 2021
679 filings reported holding SNY - Sanofi - Common Stock and American Depositary Receipts as of Q4 2021.
Sanofi - Common Stock and American Depositary Receipts (SNY) has 602 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 244M shares
of 1.23B outstanding shares and own 19.89% of the company stock.
Largest 10 shareholders include Dodge & Cox (93.4M shares), Fisher Asset Management, LLC (18M shares), FMR LLC (17.2M shares), BlackRock Inc. (13.1M shares), BANK OF AMERICA CORP /DE/ (10.5M shares), Boston Partners (6.94M shares), PRICE T ROWE ASSOCIATES INC /MD/ (6.14M shares), Invesco Ltd. (4.97M shares), HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC (4.75M shares), and Camber Capital Management LP (3.8M shares).
This table shows the top 602 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.